Background: Patients with schizophrenia suffer from wide range of deficits in neurocognitive functions of the brain, including visuospatial working memory.
Aims: This study aims at evaluating the effect of short-term smoking abstinence on different components of visuospatial working memory in smoker patients with schizophrenia as well as possible reversal effect of a nicotine patch.
Methods: In this trial, 45 male smoker patients with schizophrenia (Razi Hospital, Tabriz, Iran, 2010) were randomly divided into three groups. One group experienced a short time (overnight) smoking abstinence; one group used a single dose of nicotine patch (21 mg) after an overnight smoking abstinence and one group with no intervention or restrain on smoking was considered as control. The function of visuospatial working memory was tested by the brief visuospatial memory test-revised (BVMT-R) at the baseline and after the intervention.
Results: The three groups were matched regarding age, educational level and the initial elements of cognitive performance. Between-the-group analysis showed that patients with an overnight smoking abstinence had a significant decrease in percent retained score and an increase in recognition biases compared to patients using nicotine patch and controls. No significant changes were observed in patints using nicotine patch or controls.
Conclusions: Smoking abstinence results in visuospatial disabilities in male smoker patients with schizophrenia, including delayed recall and recognition biases.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/08039488.2012.687765 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Circulating Levels of Glial Cell Line-Derived Neurotrophic Factor (GDNF) in Schizophrenia: a systematic review and meta-analysis.
BMC Psychiatry
January 2025
Clinical Research Development Center, Imam Khomeini and Mohammad Kermanshahi and Farabi Hospitals, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Background: Glial cell line-derived neurotrophic factor (GDNF) has emerged as a potential biomarker for schizophrenia (SCZ). However, GDNF levels remain unclear in affected individuals compared to healthy controls. Therefore, we aimed to calculate a pooled estimate of GDNF levels in patients with SCZ in comparison with healthy controls.
View Article and Find Full Text PDFAlterations in fecal bacteriome virome interplay and microbiota-derived dysfunction in patients with schizophrenia.
Transl Psychiatry
January 2025
Mental Health Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Rising studies have consistently reported gut bacteriome alterations in schizophrenia (SCZ). However, little is known about the role of the gut virome on shaping the gut bacteriome in SCZ. Here in, we sequenced the fecal virome, bacteriome, and host peripheral metabolome in 49 SCZ patients and 49 health controls (HCs).
View Article and Find Full Text PDFDistribution and correlates of long-acting injectable antipsychotic use among community mental health center patients.
Psychiatry Res
January 2025
South Carolina Department of Mental Health, 220 Executive Dr, Greer, SC 29651, United States; Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, 15 Medical Park, Suite 301, Columbia, SC 29203, United States.
Although long-acting injectable antipsychotics (LAIs) are an important pharmaceutical option in the management of schizophrenia and related disorders, little is known about patient characteristics related to LAI use in real-world outpatient settings. We analyzed electronic medical records from 41,401 patients who received psychiatric services from one of 16 regional mental health centers operated by the South Carolina Department of Mental Health in 2022. We compared the use of first- and second-generation LAIs and oral antipsychotics by sociodemographic (age, gender, race/ethnicity, zip code, payment source) and clinical characteristics (psychiatric diagnoses, service use).
View Article and Find Full Text PDFMisidentification syndromes: A retrospective study from India.
Asian J Psychiatr
January 2025
Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Delusional misidentification syndromes (DMS) are rare neuropsychiatric syndromes. Most of the available data on DMS is from the developed countries. The present retrospective analysis was conducted on patients utilizing the psychiatry services in a North Indian tertiary care hospital.
View Article and Find Full Text PDFAntipsychotic medication non-adherence and its determinants among out-patients with schizophrenia.
Malawi Med J
January 2025
Nnamdi Azikiwe University Ringgold standard institution - Department of Mental Health, Nnewi Campus, Nnewi, Anambra, Nigeria.
Introduction: While antipsychotics are key requirement in acute and long-term management of schizophrenia, medication adherence remains a major unmet need in its care. This paper assessed the prevalence of oral antipsychotic non-adherence among outpatients with schizophrenia and its associated clinico-demographic factors.
Method: Three hundred and ten adult outpatients (18-64 years of age) were cross-sectionally interviewed after being diagnosed of schizophrenia using ICD-10 criteria, and the diagnosis confirmed with the Mini International Neuropsychiatric Interview (MINI).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!